Topic: Market Developments

Latest content

Why re-exams can be a good option at the USPTO

Featured in Special Report 2021 Q4: IP5 insights

29 November 2021

Recent validity trends at China's Patent Office

Featured in Special Report 2021 Q4: IP5 insights

29 November 2021

Benchmarking the IP5

Featured in Special Report 2021 Q4: IP5 insights

29 November 2021

Novo Nordisk’s $3.3 billion Dicerna purchase shows booming RNA IP market

Danish company makes its biggest-ever acquisition in an area where demand for assets is growing rapidly

23 November 2021

US patent system due for a mid-course correction, says IBM's IP business head

Bill LaFontaine says the current challenging licensing environment stems not only from legal and policy factors, but also from a widespread cultural shift that has normalised infringement

22 November 2021

The IP story to engage the c-suite is there, but it takes bravery to tell it

Saturday Opinion: After a highly successful IPBC in Seattle earlier this week, it is clear that there has never been a better time to take the value creation gospel to the boardroom

20 November 2021

Chinese patent litigation data: what it tells us and what it doesn’t

The Long Read: Exclusive analysis from Rouse and Berkeley Law’s Mark Cohen suggests that the country's courts publish only around half of the judgments that they hand down, often months after the fact. But the information that is available still has strategic value if you know what to look out for

17 November 2021

IPBC Global ends with questions about IP in the boardroom at the top of the agenda

The final day of this year’s event in Seattle saw some of the market’s biggest names explain how to get the attention of the c-suite

17 November 2021

IP data analytics providers still struggling to find tools that work for a changing world

A rise in less experienced users of their services has required platforms to design products that speak to the needs of two very different types of consumers

12 November 2021

A $650 million deal is the latest in a growing number of CRISPR IP transactions

Last week’s licensing agreement between Mammoth and Vertex shows how deal-making in the space is gathering momentum

05 November 2021

Get unlimited access to all IAM content